CentuRecon XstalBio

Developing disruptive technologies for formulating and delivering biologics

[Jamie Hepburn MSP @jamiehepburn]

@XstalBio thanks for having me, and thanks for my first practical chemistry lesson in over twenty years

[Biotechnology and Biological Sciences Research @BBSRC]

Our impact: BBSRC-funded research from @GlasgowUni @UniStrathclyde leads to spin-out company @XstalBio http://t.co/4u2QWzI6QP #drugdelivery

[CentuRecon XstalBio @CentuRecon]

Looking forward to meeting new faces @SMIpharm #lyophilisation USA conference today - a very interesting program #pharma @xstalbio

[SAE Media Group Pharma 💊 @SAEMGPharma]

Can new technologies signal the end of #freezedrying? Join the debate this Wednesday at #Lyophilisation & #FreezeDry…https://t.co/peDjXfVUuW

[XstalBio @XstalBio]

XstalBio is chosen as formulation partner in world leading consortium developing parasite #vaccines #PARAGONE http://t.co/GCUTXx9Byd

[XstalBio @XstalBio]

Parasite vaccines on the horizon! XB begins work on project to develop #vaccines in PARAGONE collaboration http://t.co/adYdrRhx6t

[CentuRecon XstalBio @CentuRecon]

Protein drug substance processed to stable dry powder (>7yr API) for later recon at any concentration #BES15 #mAbs http://t.co/PUX84rJ9Lm

[XstalBio @XstalBio]

Delivering Disruptive Technologies: US Patent Issued for Stabilization of Therapeutic Proteins #BES15 #biotech #mAbs http://t.co/EN2UegtkTs

[CentuRecon XstalBio @CentuRecon]

Reconstitute lyophilized mAbs to high concentration rapidly and without foaming http://t.co/HMd6cBODDo #BES15 #biotech

[CentuRecon XstalBio @CentuRecon]

Patient convenient delivery of therapeutic proteins - shipped as dry powders dispensed as solutions #BES15 #biotech

[CentuRecon XstalBio @CentuRecon]

Are you seeking disruptive technologies for formulating, stabilizing and delivering proteins or vaccines? #BES15 http://t.co/09hgj4oStp …

[CentuRecon XstalBio @CentuRecon]

US Patent issued for stabilization of therapeutic proteins will enable convenient patient delivery http://t.co/pDqf5oe3wC … #BES15 #biotech

[Natasha Davie @natashadavie]

"By 2030, 50% of registered medicines will be biologics" David Solomon of Bionor Pharma #pharmasummit

[CentuRecon XstalBio @CentuRecon]

Is consolidation of vaccine industry reducing opportunity for SME to partner on innovative #AMR vaccine development? #pharmasummit @xstalbio

[ISNTD @ISNTD_Press]

#pharmasummit Pr Jeremy Farrar @wellcometrust - vaccines critical in controlling antimicrobial resistance

[CentuRecon XstalBio @CentuRecon]

Would new vaccines be a better long-term response to AMR than new antibiotics? #pharmasummit @xstalbio developing stable oral vaccines

[CentuRecon XstalBio @CentuRecon]

US Patent issued for stabilization of therapeutic proteins will enable convenient patient delivery http://t.co/pDqf5oe3wC #PharmaSummit

[CentuRecon XstalBio @CentuRecon]

Are you seeking disruptive technologies for formulating, stabilizing and delivering biologics? #biopartnering http://t.co/09hgj4oStp

[CentuRecon XstalBio @CentuRecon]

US Patent Issued for Stabilization of Therapeutic Proteins #biopartnering http://t.co/pDqf5oe3wC

[CentuRecon XstalBio @CentuRecon]

Stabilization of therapeutic proteins to enable high concentration delivery in issued US Patent #biotech #pharma http://t.co/pDqf5oe3wC …